Vagal stimulation suppresses ischemia-induced myocardial interstitial myoglobin release

Life Sciences

Volumn 83, Issue 13-14, 2008, Pages 490-495

  Kawada, Toru ^a   Yamazaki, Toji ^a   Akiyama, Tsuyoshi ^a   Kitagawa, Hirotoshi ^b   Shimizu, Shuji ^a   Mizuno, Masaki ^a   Li, Meihua ^a   Sugimachi, Masaru ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Cardiac microdialysis; Cats; Coronary artery occlusion

Indexed keywords

MYOGLOBIN; PHOSPHATIDYLINOSITOL 3 KINASE; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY OCCLUSION; ARTICLE; ARTIFICIAL HEART PACEMAKER; CAT; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; IN VIVO STUDY; INTERSTITIUM; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; VAGUS NERVE STIMULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; BRADYCARDIA; CARDIAC PACING, ARTIFICIAL; CATS; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION THERAPY; HEART; MICRODIALYSIS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOGLOBIN; PHOSPHODIESTERASE INHIBITORS; VAGUS NERVE;

HELIOTHIS ZEA VIRUS 1;

EID: 52049120797     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.07.013     Document Type: Article

References (31)

1. Akiyama T., Yamazaki T., and Ninomiya I. In vivo detection of endogenous acetylcholine release in cat ventricles. American Journal of Physiology 266 3 Pt 2 (1994) H854-H860
2. Bopassa J.C., Ferrera R., Gateau-Roesch O., Couture-Lepetit E., and Ovize M. PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovascular Research 69 1 (2006) 178-185
3. Buck J.D., Warltier D.C., Hardman H.F., and Gross G.J. Effects of sotalol and vagal stimulation on ischemic myocardial blood flow distribution in the canine heart. The Journal of Pharmacology and Experimental Therapeutics 216 2 (1981) 347-351
4. Cheng Y., George I., Yi G.H., Reiken S., Gu A., Tao Y.K., Muraskin J., Qin S., He K.L., Hay I., Yu K., Oz M.C., Burkhoff D., Holmes J., and Wang J. Bradycardic therapy improves left ventricular function and remodeling in dogs with coronary embolization-induced chronic heart failure. The Journal of Pharmacology and Experimental Therapeutics 321 2 (2007) 496-476
5. Feigl E.O. Parasympathetic control of coronary blood flow in dogs. Circulation Research 25 5 (1969) 509-519
6. Feliciano L., and Henning R.J. Vagal nerve stimulation releases vasoactive intestinal peptide which significantly increases coronary artery blood flow. Cardiovascular Research 40 1 (1998) 45-55
7. Glantz S.A. Primer of Biostatistics. 5th ed. (2002), McGraw-Hill, New York
8. Hausenloy D.J., and Yellon D.M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovascular Research 61 3 (2004) 448-460
9. Henning R.J., and Sawmiller D.R. Vasoactive intestinal peptide: cardiovascular effects. Cardiovascular Research 49 1 (2001) 27-37
10. Kawada T., Yamazaki T., Akiyama T., Mori H., Inagaki M., Shishido T., Takaki H., Sugimachi M., and Sunagawa K. Effects of brief ischaemia on myocardial acetylcholine and noradrenaline levels in anaesthetized cats. Autonomic Neuroscience: Basic and Clinical 95 1-2 (2002) 37-42
11. Kawada T., Yamazaki T., Akiyama T., Li M., Ariumi H., Mori H., Sunagawa K., and Sugimachi M. Vagal stimulation suppresses ischemia-induced myocardial interstitial norepinephrine release. Life Sciences 78 8 (2006) 882-887
12. Kitagawa H., Yamazaki T., Akiyama T., Sugimachi M., Sunagawa K., and Mori H. Microdialysis separately monitors myocardial interstitial myoglobin during ischemia and reperfusion. American Journal of Physiology. Heart and Circulatory Physiology 289 2 (2005) H924-H930
13. Lazdunski M., Frelin C., and Vigne P. The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. Journal of Molecular and Cellular Cardiology 17 11 (1985) 1029-1042
14. Li M., Zheng C., Sato T., Kawada T., Sugimachi M., and Sunagawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 109 1 (2004) 120-124
15. Maughan W.L., Sunagawa K., Burkhoff D., Graves Jr. W.L., Hunter W.C., and Sagawa K. Effect of heart rate on the canine end-systolic pressure-volume relationship. Circulation 72 3 (1985) 654-659
16. Myers R.W., Pearlman A.S., Hyman R.M., Goldstein R.A., Kent K.M., Goldstein R.E., and Epstein S.E. Beneficial effects of vagal stimulation and bradycardia during experimental acute myocardial ischemia. Circulation 49 5 (1974) 943-947
17. Nabutovsky Y., Florio J., Morgan K., Grill W.M., and Farazi T.G. Lead design and initial applications of a new lead for long-term endovascular vagal stimulation. Pacing and Clinical Electrophysiology 30 11 (2007) S215-S218
18. Nakayama Y., Miyano H., Shishido T., Inagaki M., Kawada T., Sugimachi M., and Sunagawa K. Heart rate-independent vagal effect on end-systolic elastance of the canine left ventricle under various levels of sympathetic tone. Circulation 104 19 (2001) 2277-2279
19. ATP channel opening. Journal of Molecular and Cellular Cardiology 35 6 (2003) 653-660
20. Piper H.M. Energy deficiency, calcium overload or oxidative stress: possible causes of irreversible ischemic myocardial injury. Klinische Wochenschrift 67 9 (1989) 465-476
21. Piper H.M., Abdallah Y., and Schäfer C. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovascular Research 61 3 (2004) 365-371
22. Przyklenk K., and Kloner R.A. Low-dose i.v. acetylcholine acts as a "preconditioning-mimetic" in the canine model. Journal of Cardiac Surgery 10 4 (1995) 389-395
23. Qin Q., Downey J.M., and Cohen M.V. Acetylcholine but not adenosine triggers preconditioning through PI3-kinase and a tyrosine kinase. American Journal of Physiology. Heart and Circulatory Physiology 284 2 (2003) H727-H734
24. Reid J.V.O., Ito B.R., Huang A.H., Buffington C.W., and Feigl E.O. Parasympathetic control of transmural coronary blood flow in dogs. American Journal of Physiology 249 2 Pt 2 (1985) H337-H343
25. Rosenshtraukh L., Danilo Jr. P., Anyukhovsky E.P., Steinberg S.F., Rybin V., Brittain-Valenti K., Molina-Viamonte V., and Rosen M.R. Mechanisms for vagal modulation of ventricular repolarization and of coronary occlusion-induced lethal arrhythmias in cats. Circulation Research 75 4 (1994) 722-732
26. Sammel N.L., Norris R.M., Hughes C.F., Johnson R.N., Ashton N.G., and Elliott R.L. Severity of canine myocardial infarcts in relation to indices of oxygen demand: preservation of myocardial creatine kinase activity by vagal stimulation and propranolol. Cardiovascular Research 17 1 (1983) 50-60
27. Shinke T., Takeuchi M., Takaoka H., and Yokoyama M. Beneficial effects of heart rate reduction on cardiac mechanics and energetics in patients with left ventricular dysfunction. Japanese Circulation Journal 63 12 (1999) 957-964
28. Takami H., Matsuda H., Kuki S., Nishimura M., Kawashima Y., Watari H., Furuya E., and Tagawa K. Leakage of cytoplasmic enzymes from rat heart by the stress of cardiac beating after increase in cell membrane fragility by anoxia. Pflügers Archiv 416 1-2 (1990) 144-150
29. Vanoli E., de Ferrari G.M., Stramba-Badiale M., Hull Jr. S.S., Foreman R.D., and Schwartz P.J. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circulation Research 68 5 (1991) 1471-1481
30. Wienen W., and Kammermeier H. Intra- and extracellular markers in interstitial transudate of perfused rat hearts. American Journal of Physiology 254 4 Pt 2 (1988) H785-H794
31. Young L.H., Ikeda Y., Scalia R., and Lefer A.M. Wortmannin, a potent antineutrophil agent, exerts cardioprotective effects in myocardial ischemia/reperfusion. The Journal of Pharmacology and Experimental Therapeutics 295 1 (2000) 37-43